Overview

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess the demographic, clinical and imaging associations with the presence of microbleeds in atypical Alzheimer's disease. The primary hypothesis is that cognitive and functional performance will be poorer in atypical Alzheimer's subjects with microbleeds compared to those without microbleeds.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Corticosterone